arrow
D

Dario Cattaneo

Humanitas University
H指数:43
被引数:8,431

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-acting cabotegravir and rilpivirine in people with HIV and cancer: Virological eligibility and DDI considerations

长效卡博格韦和利匹韦林在HIV和癌症患者中的应用:病毒学适宜性及DDI考量

2026-09-120
PRE
Rapid achievement of protective cabotegravir concentrations in a real-world HIV PrEP cohort

在真实世界HIV PrEP队列中快速达到保护性卡博特格韦浓度

2026-07-010
OAAI
Therapeutic Drug Monitoring of Antifungal Agents: Toward Harmonization of Therapeutic Ranges

抗真菌药物的治疗药物监测:朝向治疗范围的协调统一

2026-01-010
PRE
Thrice-weekly teicoplanin: an old drug for modern needs. Experience of its use as outpatient parenteral antibiotic therapy (OPAT) at infectious disease unit of Manzoni hospital (Lecco)

每周三次替考拉宁:一种满足现代需求的旧药。在Manzoni医院(Lecco)传染病科将其作为门诊患者静脉抗生素治疗(OPAT)的经验。

2025-10-010
PRE
Temocillin: A Narrative Review of Its Clinical Reappraisal

替卡西林:对其临床再评估的叙事性综述

2025-09-220
OAAI
Why do echinocandins fail? Identifying Key Predictors to Improve Clinical Outcomes of Candida Bloodstream Infections: a Retrospective Multicentre Cohort Study

为什么棘白菌素治疗失败?识别关键预测因子以改善念珠菌血流感染的临床结局:一项回顾性多中心队列研究

2025-09-030
OAAI
Temocillin: A Narrative Review of Its Clinical Reappraisal

替莫西林:对其临床再评价的叙述性综述

2025-08-270
PRE
Assessment of potential drug-drug interactions in patients with hereditary angioedema from the ITACA cohort: simulations from a real-life dataset considering danazol versus berotralstat

对遗传性血管性水肿患者中潜在药物-药物相互作用的评估:来自ITACA队列的研究,基于真实世界数据集的模拟,比较达那唑与贝洛曲stat的差异

2025-04-250
OA
Management of polypharmacy and potential drug-drug interactions in people with HIV and cancer: insights from a 4-year multidisciplinary clinic experience

HIV和癌症患者中多重用药及潜在药物-药物相互作用的管理:来自4年多学科门诊经验的见解

2025-04-070
PRE
Appropriateness of loading dose and TDM in patients treated with teicoplanin: a single-centre observational retrospective cohort study comparing single-daily and thrice-weekly regimens
2025-03-010
PRE